FIND A DOCTOR WHO WILL PRESCRIBE IVERMECTIN, HYDROXYCHLOROQUINE AND EARLY OUTPATIENT TREATMENTS FOR COVID-19 (IN VARIOUS COUNTRIES)

Treatment should start based on clinical suspicion as soon as possible, preferably within the first 3 days of symptoms. Perform PCR testing, but do not withhold treatment pending results.

Note: IVM = Ivermectin

See the directory of professionals in various countries below.

Global Directory of Doctors (by Country) Prescribing Effective Outpatient COVID-19 Therapy

MULTIPLE COUNTRIES (Telemedicine)

Dr. Darrell DeMello (IVM)      +91-7718079507   darrelldemello@gmail.com

Dr. Fabio Lopes Bueno Netto      +55 (11) 9 9118 5051(Tel / WhatsApp)    fabio@buenonetto.com

AFGHANISTAN

Dr. M. Anwar Noor (IVM)      +93-775313155     anwarnoor285@gmail.com

ARGENTINA

States using IVM: Corrientes, Jujuy, Misiones, Pampa, Salta, Santa Cruz, Tucuman

Dr. Hector Eduardo Carvallo (IVM)                   11 4389 1215

Dr. Maria Eugenia Farinella (IVM)                     11 4389 1215

Dr. Roberto Raul Hirsch (IVM)                           11 4360 5700

Dr. Rodrigo Zoni (IVM)                                       54 379 441 00 00

AUSTRALIA (Australian doctor who will prescribe ivermectin)

Dr. Peter Lewis (IVM)                                          3 9822 9996

BANGLADESH

Dr. Mohammad Tarek Alam (IVM)                     9120792 93

BELIZE

IVM approved by Belize’s Ministry of Health as a prescription treatment option for Covid-19

BOLIVIA

Bolivian government added IVM to its guidelines for treating coronavirus infections in May 2020

Dr. Andres Zurita (IVM)                                     +79606228793      andreszc1.11.111@gmail.com      (consultations by telemedine for all Bolivia)

 

BRASIL (BRAZIL)

Cities using IVM: Belem, Fortaleza,Itajai, Paranagua, Porto Alegre, Porto Feliz
Dr. Wilton Adriano wadrianocc@gmail.com (Golania, Goias)
Dr. Felipe Dias Wanderley de Carvalho diasds1313@gmail.com (Belo Horizonte, Minas Gerais)
Dr. Lucy Kerr 55 11 3287 3755 (São Paulo)
Dr. Maria de Fátima Gomes de Luna mfgdeluna@gmail.com (Fortaleza, Ceará)
Dr. Carolina Muniz carolina.munizferreira@yahoo.com (Rio de Janeiro)
Dr. Jussara Resende 55 11 98825 6308 (São Paulo)
Dr. Claudia de Bessa Solmucci 31 4009 8200 cbsolmucci@gmail.com (Belo Horizonte, Minas Gerais)

BULGARIA

Use of IVM for COVID-19 treatment is common

 

CAMEROON

Dr. Sam Enoh (IVM)                                            samuelenohtanya@gmail.com 


CAMBODIA

Ivermectin Included in National Government Protocol for Treating COVID-19


CANADA

BC CDC, Alberta Health Services: IVM not recommended for COVID-19 outside of approved clinical trials (April 21, 2021)
However, no COVID-19-related IVM clinical trials have been authorized by Health Canada as of May 23, 2021
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/list-authorized-trials.html#a2

 

CZECH REPUBLIC

Physicians can prescribe Ivermectin for COVID-19 patients; then report it in the Infectious Diseases Information System

CUBA

HCQ available; IVM being tested for COVID-19 treatment

DOMINICAN REPUBLIC

IVM is used widely both for prophylaxis and for treatment of COVID-19. Some doctors use HCQ as well.

Dr. José Natalio Redondo Galan (IVM)            josenatalioredondo@gmail.com

EGYPT

National treatment guidelines issued November 2020

EL SALAVDOR

Government sanctioned protocol includes IVM  https://pbs.twimg.com/media/EYmTD7kXsAIh2L_?format=jpg&name=large

FRANCE

IVM generally available for COVID-19 but patient may have to request it ... IVM not included in national guidelines

Coordination Santé Libre     https://stopcovid19.today/

Dr. Sabine Paliard-Franco (HCQ)                      3 81 07 62 64

Dr. Denis Gastaldi (HCQ)                                  3 87 86 31 05

Dr. Jean-Jacques Erbstein (HCQ)                     3 87 94 49 71

GUATEMALA

Dr. Jorge Alfonso Lemus (IVM)                         WhatsApp 502 5391 7777  (Guatemala City)

HONDURAS

Government approved protocol includes IVM and HCQ

HUNGARY

Clinical trial of IVM for COVID-19 treatment  at the South Pest Central Hospital and the National Institute of Pulmonology 

 

INDIA

Most of India uses IVM in the first line of treatment for COVID-19

Dr. Rakesh Arora (IVM)                                       97792114  

Dr. V. K. Arora (IVM)                                           120 4880077

Dr. Digambar Behera (IVM)                              172 274 7585  

Dr. Darrell DeMello (IVM)                                  7718079507   (Mumbai)  darrelldemello@gmail.com

Dr. Bhupesh Dewan (IVM)                                 22 30610000

Dr. Jagadish G Donki (IVM)                               9845917230   (Bangalore) doctor333in@yahoo.co.in 

also treats long Covid-19 (Post COVID Syndrome)

Dr. Surya Kant (IVM)                                           522 2255167    

Dr. Rahul Mayekar (IVM)                                    22 2406 3000

Dr. Parthiv Mehta (IVM)                                     757 500 4800

Dr. Narayana Pradeep (IVM)                             949 6358176

Dr. P. Sarat Singh (IVM)                                      38 5244 3144

Dr. Mohankumar Thekkinkatti (IVM)l                759 8110066

Dr. Agam Vora (IVM)                                          22 2895 4811  

Dr. Asiya Kamber Zaidi (IVM)                           asiyazaidia@gmail.com


Clinical Trial - NCT04373824 (Recruiting)

Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation)
New Delhi, Delhi, India, 110017
Contact: Rajesh Saxena, MBA 9818474003 rajesh.saxena@maxhealthcare.com 
Principal Investigator: Sandeep Budhiraja, MRCP, FACP - 9810262954 sbudhiraja@maxhealthcare.com

Sub-Investigator: Ram Shankar Mishra, DNB, FRCP - 9810193145 docmishra@yahoo.co.in



INDONESIA

Ivermectin permission to treat COVID-19 from the Food and Drug Supervisory Agency (BPOM) and from Ministry of Health

https://www.solotrust.com//read/37899/Indonesia-Pakai-Ivermectin-Untuk-Obat-Terapi-Covid-19#


ISRAEL

Dr. Eli Schwartz (IVM)                                         03-5305000



ITALY
IVM for COVID-19 information at:  https://www.farmagalenica.it/ivermectina-contro-covid-capsule-galeniche-in-farmacia/ 

Clinical Trial - NCT04438850 (Recruiting)
Contact: Zeno Bisoffi, PhD +390456013326 zeno.bisoffi@sacrocuore.it 

IRCCS Sacro Cuore Don Calabria hospital
Negrar, Verona, Italy, 37024
Contact: Dora Buonfrate dora.buonfrate@sacrocuore.it 
Principal Investigator: Zeno Bisoffi 
Sub-Investigator: Dora Buonfrate 
  
Policlinico S. Orsola 
Bologna, Italy
Contact: Luciano Attard 
  
Ospedale Luigi Sacco 
Milan, Italy
Contact: Spinello Antinori 
  
Ospedale di Rovereto 
Rovereto, Italy
Contact: Giovanni Pedrotti 

 

JAMAICA

Ministry of Health & Wellness does not recommend for or against IVM in COVID-19 treatment (March 2021)

The Ministry recognizes that some doctors are using IVM for treatment of COVID-19

JAPAN

  • Greenlight for Ivermectin in Japan (18 Aug 2021)
  • Dr. Haruo Ozaki, chairman, Tokyo Medical Association, recommends use of Ivermectin for COVID-19 patients (9 Feb 2021)
  • Tokyo Metropolitan Government plans clinical trials of Ivermectin for outpatient treatment of COVID-19 (30 Jan 2021)​

MACEDONIA

IVM for COVID-19 treatment approved by MALMED Drug Agency for North Macedonia

MEXICO

States using IVM:  Chiapas

Mexico City government is giving away COVID-19 kits with Ivermectin & Azythtromycin through kiosks.

Dr. Guadalupe Espitia Hernández (IVM)          55 54471424 ext 13272  (Mexico City)

Dr. Ezequiel Jose Castro Ortiz (IVM)                drecastro@live.com (Monterrey)

Dr. José Humberto Galindo Rendón (IVM)      (492) 156 0805  (Zacatecas)

NICARAGUA

National treatment guidelines issued January 2021

 

NIGERIA

Clinical trial ​approved in Lagos state for Ivermectin treatment of Covid-19

PAKISTAN

Dr. Najma Parveen (IVM)                                   322 5335786

Dr. Sohaib Ashraf (IVM)                                      333 447452

PANAMA

Government has approved and stockpiled IVM and HCQ

PARAGUAY

States using IVM: Alto Parna

PERU

National treatment guidelines issued January 2021

Dr. Gustavo Aguirre Chang (IVM)                     Facebook: Gustavo Aguirre             

Dr. Carlos Calampa Del Águila (IVM)               1 641 9847

Dr. Antonio Camargo  (IVM)                             WhatsApp +51 942610346       dr@antoniocamargo.com

Dr. Risof Solis Cóndor (IVM)                             risofneumologia@gmail.com

Dr. Jose Eduardo Gotuzzo Heritage (IVM)      1 319 0000

Dr. Yiduv Pettyd Ordoñez Romero (IVM)         yiduv@hotmail.com

PHILIPPINES

A licensed physician may prescribe IVM off label at his/her own discretion in consultation with the patient
Dr. Allan A. Landrito (IVM) 09323137060 dr.allan.landrito@gmail.com

POLAND

Dr. Włodzimierz Bodnar (Amantadine), +48 16 677 00 79, +48 16 671 87 77; https://przychodnia-przemysl.pl

SLOVAKIA

January 27, 2021: The Health Ministry approved the therapeutic use of Ivermectin for six months

SOUTH AFRICA

Court order determines that physicians, on their own judgement, may prescribe IVM for treatment of COVID-19 (April 6, 2021)

Dr. Shankara Chetty                                  846102030      please WhatsApp

Dr. Alex Ekonomakis                                 117961400

Dr. Chantelle Eybers                                 716248492      Dreybers@slendermed.co.za

Dr. Liandi Fourie                                        126530564

Dr. Hema Kalan                                          126632732      info@drhemakalan.com

Dr. Gerrie Lindeque                                   568172275      info@comppharm.co.za       Whatsapp: 060 528 2910

Dr. Claudia Boitshoko Moloabi                                        info@drclaudiamoloabi.com      (IVM prescribed for Covid 19 prophylaxis)

Dr. Zodwa Ngobese                                  824449268

Dr. Gys du Plessis                                      104428929

Dr. Marna Turner                                        834724948

Dr. Mariska van Tonder                             792899753

Dr. Gerhard Vosloo                                   123465935

Bendiga House                                         083/487-4797    info@bendigahouse.org.za            https://www.bendigahouse.org.za/

My Free Doctor                                         +1 850-750-1322   Text        http://www.myfreedoctor.com

 

SPAIN

Dr. Marina Bucar Barjud (HCQ)                      +34 902 089 800



United Kingdom

Clinical Trial - NCT04632706 (Recruiting)

Contact: Chief Development Officer +33 698 459099 joel.richard@medincell.com 

MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence Recruiting
Manchester, Greater Mancherster, United Kingdom, M13 9NQ
Contact: R Kelshaw +44 (0) 161 275 9966 robbiekelshaw@macplc.com 
Contact: L Cheung +44 (0) 161 274 5400 louisacheung@macplc.com 
Principal Investigator: P M Leung 
  

USA

(see Find a Doctor to Prescribe Ivermectin in US)

VENEZUELA

Government approved COVID-19 treatment protocol includes IVM and HCQ

ZIMBABWE

The Medicines Control Authority of Zimbabwe (MCAZ) has approved use of IVM for prophylaxis and treatment of COVID-19 

Dr. Jackie Stone  https://www.facebook.com/jackie.stone.39794


------------------


Disclaimer: Information is not guaranteed to be accurate. A particular medical professional currently may not be accepting new patients.


Source: https://www.exstnc.com

Find a Doctor who will prescribe Hydroxychloroquine and Ivermectin
McCullough et al (2021)

Frequently Asked Questions

Do you need a prescription for hydroxychloroquine​?
Yes, hydroxychloroquine is a prescription drug and you do need it to be prescribed to you by a doctor. 

Can hydroxychloroquine (HCQ) be purchased over the counter?
No. Hydroxychloroquine or Ivermectin are not an OTC (over-the-counter) drug like Tylenol or Nexium where you can just buy it from your local pharmacy. Therefore, the standard route of requiring a prescription and then having a pharmacist fill the prescription is required. On how to get hydroxychloroquine prescription, please refer to the directory above.

COVID-19 Clinical Study Tracking and Meta-analysis


What's New


Results of Ivermectin's success in treating COVID-19 outbreaks in India, Mexico, Peru, Paraquay, Argentina, Brazil and Slovakia.

June 1, 2021: The Drug that Obliterates 97% of New Delhi Cases by Justus R. Hope, MD


May 19, 2021 - A study by Juan Chamie, Jennifer Hibberd of the University of Toronto and David Scheim of the US Public Health Service, shows the sharp rise, fall and resurgence in excess deaths (among the over 60 year-old cohort) in Peru as the virus waxed, waned and waxed again.

May 16, 2021: Do the NIH and WHO COVID treatment recommendations need to be fixed by Steve Kirsch. 
"Great article on where we stand on the COVID-19 treatment front debate" - COVID19Crusher

April 24, 2021 - The All India Institute of Medical Sciences and Indian Council of Medical Research (ICMR) have issued new guidelines for COVID-19 treatment based on three levels of seriousness--mild, moderate and severe.

Feb 9, 2021 - Ivermectin plus Azithromycin plus Montelukast plus Aspirin totally crush Covid-19 in propective Mexican study (n=768). The TNR4 multidrug therapy (New Therapy for Recovery of COVID-19 infection, 4 medications; in Spanish: Terapia Nueva para la Recuperación en la infección por COVID19, 4 medicamentos).
Lima-Morales R, Mendez-Hernandez P, Flores YN, Osorno-Romero P, Cuecuecha-Rugerio E, Nava-Zamora A, Hernandez-Galdamez DR, Romo-Duenas DK, Salmeron J, Effectiveness of a multidrug therapy consisting of ivermectin, azithromycin, montelukast and acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico, International Journal of Infectious Diseases (2021), doi: https://doi.org/10.1016/j.ijid.2021.02.014

Feb 8, 2021 - Successful UK randomized trial (STOIC - Steroids in COVID-19) of 146 outpatient inhaled budesonide, with 90% reduction in need for urgent care, ED or hospitalization. Median/avg clinical recovery 1/3 days quicker. 

Feb 4, 2021 - Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial
RCT of PCR+ patients with Ct<=20 with 12 treatment and 12 control patients, concluding that nasopharyngeal decolonization may reduce the carriage of infectious SARS-CoV-2 in adults with mild to moderate COVID-19. All patients but 1 had negative viral titer by day 3 (group not specified). There was no significant difference in viral RNA quantification over time. The mean relative difference in viral titers between baseline and day 1 was 75% [43%-95%] in the intervention group and 32% [10%-65%] in the control group. Thyroid dysfunction occurred in 42% of treated patients, with spontaneous resolution after the end of treatment. Patients in the treatment group were younger.
Guenezan et al., JAMA Otolaryngol Head Neck Surg., doi:10.1001/jamaoto.2020.5490 (Peer Reviewed)

Related: Betadine Gargle

Jan 7, 2021 - Early ambulatory, multidrug therapy is associated with substantial reductions in hospitalization and death compared to available rates in the community. Prompt ambulatory treatment should be offered to high-risk patients with COVID-19 instead of watchful watching and late-stage hospitalization for salvage therapies. Their early ambulatory treatment regimen was associated with estimated 87.6% and 74.9% reductions in hospitalization and death respectively, p<0.0001.
Brian Procter, Casey Ross, Vanessa Pickard, et al. Early Ambulatory Multidrug Therapy Reduces Hospitalization and Death in High-Risk Patients with SARS-CoV-2 (COVID-19)Authorea. January 07, 2021.


About the Wellness Alliance: The Wellness Alliance was formed as a working group to share information, experience and guides related to the current COVID-19 pandemic. They are a network of multi-disciplined medical professionals and senior experienced executives from corporate backgrounds within different industries who have come together, to leverage on their experience and relationships in different parts of the world and industries. Follow them on Twitter for updates.

Related:


LIMITATION OF LIABILITY


This information is provided as a not-for-profit public service. In no event shall we or our affiliates be liable for any special, incidental or consequential damages arising out of or in connection with this information or website, including negligence.

Comments

Popular Posts